RoB 2: a revised tool for assessing risk of bias in randomised trials

Abstract

Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.

Keywords

Systematic reviewMedicineRandomized controlled trialPublication biasClinical trialMEDLINEComputer scienceMeta-analysisMedical physicsInternal medicine

MeSH Terms

BiasResearch Design

Affiliated Institutions

Related Publications

Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions

Miranda Cumpston , Tianjing Li , Matthew J. Page +4 more

On a shelf in the sunny, open‐plan office of Cochrane Australia in Melbourne, there's a large, white ring‐binder that, it's fair to say, hasn't been opened in a while. It's a pr...

2019 Cochrane Database of Systematic Reviews 6591 citations

Unpublished rating scales: A major source of bias in randomised controlled trials of treatments for schizophrenia

Max Marshall , Austin Lockwood , Caroline Bradley +3 more

Background A recent review suggested an association between using unpublished scales in clinical trials and finding significant results. Aims To determine whether such an associ...

2000 The British Journal of Psychiatry 850 citations

Corticosteroids as Adjunctive Therapy in the Treatment of Influenza: An Updated Cochrane Systematic Review and Meta-analysis

Louise Lansbury , Chamira Rodrigo , Jo Leonardi‐Bee +2 more

Objectives: Corticosteroids may be beneficial in sepsis, but uncertainty remains over their effects in severe influenza. This systematic review updates the current evidence rega...

2019 Critical Care Medicine 201 citations

Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessments

Luke A. McGuinness , Julian P. T. Higgins

Despite a major increase in the range and number of software offerings now available to help researchers produce evidence syntheses, there is currently no generic tool for produ...

2020 Research Synthesis Methods 4102 citations

Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up?

Hilda Bastian , Paul Glasziou , Iain Chalmers

When Archie Cochrane reproached the medical profession for not having critical summaries of all randomised controlled trials, about 14 reports of trials were being published per...

2010 PLoS Medicine 1122 citations

Publication Info

Year: 2019
Type: letter
Volume: 366
Pages: l4898-l4898
Citations: 25948
Access: Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric

RoB 2: a revised tool for assessing risk of bias in randomised trials

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

25948

OpenAlex

1387

Influential

19672

CrossRef

Cite This

APA Style

                            
                                    Jonathan A C Sterne, 
                                
                                    Jelena Savović, 
                                
                                    Matthew J. Page
                                
                                et al.
                            
                            (2019). 
                            RoB 2: a revised tool for assessing risk of bias in randomised trials. 
                            BMJ
                            , 366
                            
                            , l4898-l4898.
                            https://doi.org/10.1136/bmj.l4898

Identifiers

DOI: 10.1136/bmj.l4898
PMID: 31462531

Data Quality

Data completeness: 86%